These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37581672)

  • 21. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
    Costantine MM; Weiner SJ;
    Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2009 Jun; 200(6):595-609. PubMed ID: 19482113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour.
    McNamara HC; Crowther CA; Brown J
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011200. PubMed ID: 26662716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal obesity and neuroprotective magnesium sulfate.
    McPherson J; Smiley S; Stamilio D
    Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.
    Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ;
    Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The MagNUM Study.
    Poppe T; Thompson B; Boardman JP; Bastin ME; Alsweiler J; Deib G; Harding JE; Crowther CA;
    EBioMedicine; 2022 Apr; 78():103923. PubMed ID: 35331677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The feasibility of a randomized clinical perinatal trial: maternal magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ; Hauth JC; Nelson KG; Goldenberg RL
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):701-5. PubMed ID: 8828437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of labour at or beyond 37 weeks' gestation.
    Middleton P; Shepherd E; Morris J; Crowther CA; Gomersall JC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD004945. PubMed ID: 32666584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Fetal Growth Restriction With Neurocognitive Function After Repeated Antenatal Betamethasone Treatment vs Placebo: Secondary Analysis of the ACTORDS Randomized Clinical Trial.
    Cartwright RD; Crowther CA; Anderson PJ; Harding JE; Doyle LW; McKinlay CJD
    JAMA Netw Open; 2019 Feb; 2(2):e187636. PubMed ID: 30707225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of biochemical tests of placental function for improving pregnancy outcome.
    Heazell AE; Whitworth M; Duley L; Thornton JG
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of an Intensive Nurse Home Visiting Program on Adverse Birth Outcomes in a Medicaid-Eligible Population: A Randomized Clinical Trial.
    McConnell MA; Rokicki S; Ayers S; Allouch F; Perreault N; Gourevitch RA; Martin MW; Zhou RA; Zera C; Hacker MR; Chien A; Bates MA; Baicker K
    JAMA; 2022 Jul; 328(1):27-37. PubMed ID: 35788794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
    Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
    JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.
    Carlo WA; McDonald SA; Fanaroff AA; Vohr BR; Stoll BJ; Ehrenkranz RA; Andrews WW; Wallace D; Das A; Bell EF; Walsh MC; Laptook AR; Shankaran S; Poindexter BB; Hale EC; Newman NS; Davis AS; Schibler K; Kennedy KA; Sánchez PJ; Van Meurs KP; Goldberg RN; Watterberg KL; Faix RG; Frantz ID; Higgins RD;
    JAMA; 2011 Dec; 306(21):2348-58. PubMed ID: 22147379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.
    Bond DM; Middleton P; Levett KM; van der Ham DP; Crowther CA; Buchanan SL; Morris J
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004735. PubMed ID: 28257562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet agents for preventing pre-eclampsia and its complications.
    Duley L; Meher S; Hunter KE; Seidler AL; Askie LM
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Translating antenatal magnesium sulphate neuroprotection for infants born <28 weeks' gestation into practice: A geographical cohort study.
    Doyle LW; Spittle AJ; Olsen JE; Kwong A; Boland RA; Lee KJ; Anderson PJ; Cheong JLY;
    Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):513-518. PubMed ID: 33528040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.